lenalidomide (AC Pharmaceuticals)

N/A

Report date: 2025/01/26 17:49:50
NME

Base Information

Drug Namelenalidomide (AC Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCereblon modulators
TargetsCereblon
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAc Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAc Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A